-
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by Analysts
Source: Buzz FX / 23 Jan 2025 03:16:18 America/New_York
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by Analysts Written by MarketBeat January 23, 2025 Share Link copied to clipboard. Shares of Rocket Pharmaceuticals, Inc.
Read more...